Clinical Trial Update: Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing Sym004 to standard of care in metastatic colorectal cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Sym004

Snippet

Sponsor: Symphogen A/S | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-12-24